These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 832589)

  • 1. [Pharmacokinetics of digitoxin in chronic renal failure (author's transl)].
    Peters U; Grabensee B; Hausamen TU; Fritsch WP; Grosse-Brockhoff F
    Dtsch Med Wochenschr; 1977 Jan; 102(4):109-15. PubMed ID: 832589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Serial tests of serum-digitoxin levels during digitoxin treatment (author's transl)].
    Peters U; Hausamen TU; Grosse-Brockhoff F
    Dtsch Med Wochenschr; 1974 Aug; 99(35):1701-7. PubMed ID: 4410846
    [No Abstract]   [Full Text] [Related]  

  • 3. [Interaction of quinidine and digitoxin in the human (author's transl)].
    Peters U; Risler T; Grabensee B; Falkenstein U; Kroukou J
    Dtsch Med Wochenschr; 1980 Mar; 105(13):438-42. PubMed ID: 7363796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Gycoside serum concentrations under maintenance therapy with Lanicor, Card-Lamuran, MF708d, and Lanitop (author's transl)].
    Weiss W; Olcay A; Teufel W; Glocke M
    Med Klin; 1975 Aug; 70(35):1367-74. PubMed ID: 809651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of alfentanil in chronic renal failure.
    Chauvin M; Lebrault C; Levron JC; Duvaldestin P
    Anesth Analg; 1987 Jan; 66(1):53-6. PubMed ID: 3099599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacokinetics of cefotaxime in patients with chronic renal impairment (author's transl)].
    Fillastre JP; Ings RM; Leroy A; Humbert G; Godin M
    Nouv Presse Med; 1981 Feb; 10(8):574-9. PubMed ID: 6259595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Digitalis therapy in renal failure with special regard to digitoxin.
    Vöhringer HF; Rietbrock N
    Int J Clin Pharmacol Ther Toxicol; 1981 Apr; 19(4):175-84. PubMed ID: 7021432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clearance concept applied to pharmacokinetics: 2. Experience with tolamolol (beta-blocking agent) in renal insufficiency (author's transl)].
    Balant L; Gorgia A; Marmy A; Tschopp JM
    Nephrologie; 1980; 1(4):177-82. PubMed ID: 6895408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antipyrine kinetics in Nigerian women in chronic renal failure.
    Iyun AO; Tucker GT
    Afr J Med Med Sci; 1982 Mar; 11(1):7-9. PubMed ID: 6291357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Meproscillarin in patients with renal failure and concomitant heart failure (author's transl)].
    Beckmann H; Belz GG; Quellhorst E
    Med Klin; 1979 Nov; 74(47):1761-6. PubMed ID: 522817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics of muzolimine in chronic heart failure.
    Storstein L; Bjørnstad H; Mølstad P
    Z Kardiol; 1985; 74 Suppl 2():34-6. PubMed ID: 4002802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prolonged half-life of digitoxin in the elderly].
    Bøhmer T; Røseth A
    Tidsskr Nor Laegeforen; 1999 Jan; 119(3):369-70. PubMed ID: 10074832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of buflomedil after intravenous administration in patients with chronic renal failure.
    Rey E; d'Athis P; Richard MO; Fillastre JP; Olive G
    Int J Clin Pharmacol Ther Toxicol; 1984 Dec; 22(12):648-52. PubMed ID: 6526539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Protein binding and hydroxylation rate of digitoxin in renal failure].
    Kuhlmann J; Pabst J
    Dtsch Med Wochenschr; 1982 Oct; 107(41):1551-5. PubMed ID: 7128466
    [No Abstract]   [Full Text] [Related]  

  • 15. [Kinetics of digitoxin during antirheumatic therapy with azapropazone (author's transl)].
    Faust-Tinnefeldt G; Gilfrich HJ
    Arzneimittelforschung; 1977; 27(10):2009-11. PubMed ID: 579114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Digitoxin in hepatorenal insufficiency].
    Maier C; Kolenda KD
    Dtsch Med Wochenschr; 1983 Sep; 108(39):1475-80. PubMed ID: 6617500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Digitoxin--rediscovered].
    Fischer M
    Med Klin; 1980 Dec; 75(25):891-3. PubMed ID: 7464638
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacokinetics of norfloxacin in chronic renal failure.
    Arrigo G; Cavaliere G; D'Amico G; Passarella E; Broccali G
    Int J Clin Pharmacol Ther Toxicol; 1985 Sep; 23(9):491-6. PubMed ID: 4055162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on digitalis. VII. Influence of nephrotic syndrome on protein binding, pharmacokinetics, and renal excretion of digitoxin and cardioactive metabolites.
    Storstein L
    Clin Pharmacol Ther; 1976 Aug; 20(2):158-66. PubMed ID: 947651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Studies on metabolism and pharmacokinetics of alpha-acetyldigitoxin in man (author's transl)].
    Bodem G; Wirth K; Dengler HJ
    Arzneimittelforschung; 1975 Sep; 25(9):1448-52. PubMed ID: 1242671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.